Strategic Partnerships Graphenea actively collaborates on graphene biosensor developments with Melexis and Grapheal, indicating a receptive market for integrated graphene sensor platforms and related development kits that can accelerate client pilots and time-to-market.

Product Portfolio A history of launching graphene-based sensors and foundry products (GFET-S30, S11/S12, mGFET) shows ongoing innovation and a breadth of sensing solutions suitable for medical diagnostics, environmental sensing, and industrial process monitoring—opportunities for upsell and cross-sell across industries.

Industry Focus Specialization in high-uniformity monolayer graphene and CMOS-compatible integration positions Graphenea to support customers pursuing scalable, repeatable graphene device production, appealing to research labs and manufacturing partners seeking reliable material and process performance.

Commercial Scale Gaps Current revenue under 1 million with a $7.3M funding runway suggests potential for early-stage customers and pilots; sales efforts can target tiered engagement with proof-of-concept projects and staged commercialization to maximize adoption and capital efficiency.

Global Footprint With presence in Spain and the US and a network of collaborations, there is an opportunity to expand regional partnerships, channel programs, and localized support to accelerate procurement cycles for multinational customers deploying graphene-based sensing solutions.